ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of
wafer processing solutions for semiconductor and advanced
wafer-level packaging applications, today reported financial
results for its third quarter ended September 30, 2024.
"I am pleased to report another strong quarter
for ACM, with record revenue and shipments, good profitability, and
positive cash flow from operations," said ACM’s President and Chief
Executive Officer, Dr. David Wang. "We believe our results
demonstrate ACM’s role as an innovator, delivering world-class
tools that drive value for our customers and strengthen our
position in the global market. Tahoe is gaining momentum with
multiple logic and memory customers in production. This tool now
delivers the same advanced cleaning performance as single-wafer
tools, and at the same time up to 75% reduction of sulfuric acid
use. We also believe the unique approach of our new panel products
– including the Ultra ECP ap-p Horizontal Plating tool, the Ultra C
vac-p Flux Cleaning tool, and the Ultra C bev-p Bevel Etching Tool
– position ACM to become a significant contributor to the global
adoption of AI chip manufacturing.”
Dr. Wang continued, "Looking ahead, we
anticipate continued growth of our business in mainland China
through market share gains and new product ramps. We have begun
initial operations at our Lingang facility, and we remain committed
to support major customers in the US, Europe, and Southeast Asia.
Our near-term outlook has improved, and as a result, we have raised
our 2024 revenue outlook."
|
Three Months Ended September 30, |
|
GAAP |
|
Non-GAAP(1) |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(dollars in thousands, except EPS) |
Revenue |
$ |
203,976 |
|
|
$ |
168,569 |
|
|
$ |
203,976 |
|
|
$ |
168,569 |
|
Gross margin |
|
51.4 |
% |
|
|
52.5 |
% |
|
|
51.6 |
% |
|
|
52.9 |
% |
Income from operations |
$ |
44,184 |
|
|
$ |
33,173 |
|
|
$ |
56,065 |
|
|
$ |
43,754 |
|
Net income attributable to ACM
Research, Inc. |
$ |
30,904 |
|
|
$ |
25,679 |
|
|
$ |
42,372 |
|
|
$ |
37,579 |
|
Basic EPS |
$ |
0.49 |
|
|
$ |
0.43 |
|
|
$ |
0.68 |
|
|
$ |
0.62 |
|
Diluted EPS |
$ |
0.45 |
|
|
$ |
0.39 |
|
|
$ |
0.63 |
|
|
$ |
0.57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
GAAP |
|
Non-GAAP(1) |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(dollars in thousands, except EPS) |
Revenue |
$ |
558,647 |
|
|
$ |
387,402 |
|
|
$ |
558,647 |
|
|
$ |
387,402 |
|
Gross margin |
|
50.3 |
% |
|
|
50.9 |
% |
|
|
50.6 |
% |
|
|
51.1 |
% |
Income from operations |
$ |
107,009 |
|
|
$ |
72,465 |
|
|
$ |
147,801 |
|
|
$ |
87,131 |
|
Net income attributable to ACM
Research, Inc. |
$ |
72,547 |
|
|
$ |
59,649 |
|
|
$ |
114,490 |
|
|
$ |
78,743 |
|
Basic EPS |
$ |
1.17 |
|
|
$ |
0.99 |
|
|
$ |
1.85 |
|
|
$ |
1.31 |
|
Diluted EPS |
$ |
1.07 |
|
|
$ |
0.90 |
|
|
$ |
1.70 |
|
|
$ |
1.19 |
|
(1) |
Reconciliations to U.S. generally accepted accounting principles
(“GAAP”) financial measures from non-GAAP financial measures are
presented below under “Reconciliation of GAAP to Non-GAAP Financial
Measures.” Non-GAAP financial measures exclude stock-based
compensation and, with respect to net income (loss) attributable to
ACM Research, Inc. and basic and diluted earnings per share, also
exclude unrealized gain (loss) on short-term investments. |
Outlook
ACM has raised its revenue guidance range for
fiscal year 2024 to a range of $725 million to $745 million from
the prior range of $695 million to $735 million. This expectation
is based on ACM management’s current assessment of the continuing
impact from international trade policy, together with various
expected spending scenarios of key customers, supply chain
constraints, and the timing of acceptances for first tools under
evaluation in the field, among other factors.
Operating Highlights and Recent
Announcements
-
Shipments. Total shipments in the third quarter of
2024 were $261 million, up 23% from the third quarter of 2023.
Total shipments include deliveries for revenue in the quarter and
deliveries of first tool systems awaiting customer acceptance for
potential revenue in future quarters.
- Major Performance
Breakthrough for Flagship Ultra C Tahoe Cleaning Tool. The
upgraded Ultra C Tahoe now achieves the performance of standalone
single-wafer cleaning tools on low-to-medium temperature sulfuric
peroxide mix (SPM) processes. The hybrid architecture delivers
enhanced cleaning performance, high throughput, and process
flexibility, with an up to 75% reduction in chemical consumption.
The upgraded Ultra C Tahoe is now in production at several
high-volume customer facilities in mainland China. Additional logic
and memory customers are evaluating the tool, and we expect to
deliver additional units through the end 2024.
- Launched
Ultra C bev-p Panel Bevel Etching Tool for Panel-Level Packaging
Applications. The new tool is specifically designed for
bevel etching and cleaning in copper-related processes and is
capable of handling both the front and back side etching within a
single system. This capability enhances process efficiency and
product reliability.
- Received
Orders for Wafer-Level Packaging Tools from U.S. Customer and
R&D Center. ACM has received purchase orders for four
wafer-level packaging tools, including two from a U.S.-based
customer and two from a U.S.-based research and development
(R&D) center. The four tools support a range of advanced
packaging processes and are scheduled for delivery in the first
half of 2025.
- Completed
Purchase of Commercial Facility in Oregon. On October 1,
2024, ACM completed the purchase of a 39,500 square foot facility,
including a 5,200 square foot functional clean room. This facility
is intended to augment ACM’s current Oregon facility and further
expand ACM’s R&D and demonstration capability in the U.S.
market.
- Opening of R&D and
Production Facility. On October 20, 2024, ACM Shanghai
celebrated the official opening of its new R&D and production
facility in Lingang, China.
Third Quarter 2024 Financial Summary
Unless otherwise noted, the following figures refer to the third
quarter of 2024 and comparisons are with the third quarter of
2023.
-
Revenue was $204.0 million, up 21%, reflecting
higher sales of single wafer cleaning, Tahoe and semi-critical
cleaning equipment and ECP (front-end and packaging), furnace and
other technologies, partly offset by lower sales of advanced
packaging (excluding ECP), services & spares.
- Gross
margin was 51.4% versus 52.5%. Non-GAAP gross margin,
which excludes stock-based compensation, was 51.6% versus 52.9%.
Gross margin exceeded ACM’s long-term business model range of 40%
to 45%. ACM expects gross margin to vary from period to period due
to a variety of factors, such as product mix, currency impacts and
sales volume.
- Operating
expenses were $60.7 million, an increase of 10%. Operating
expenses as a percentage of revenue decreased to 29.7% from 32.8%.
Non-GAAP operating expenses, which exclude the effect of
stock-based compensation, were $49.2 million, up 8.5%. Non-GAAP
operating expenses as a percentage of revenue decreased to 24.1%
from 26.9%.
- Operating
income was $44.2 million, compared to $33.2 million.
Operating margin was 21.7% compared to 19.7%. Non-GAAP operating
income, which excludes the effect of stock-based compensation, was
$56.1 million, compared to $43.8 million. Non-GAAP operating
margin, which excludes stock-based compensation, was 27.5% compared
to 26.0%.
- Unrealized
gain (loss) on short-term investments was $0.4 million,
compared to an unrealized gain (loss) of $(1.3) million. Unrealized
gain (loss) reflects the change in market value of the investments
by ACM’s principal operating subsidiary, ACM Research (Shanghai),
Inc. The value is marked-to-market quarterly and is excluded in the
non-GAAP financial metrics.
- Income tax
expense was $4.0 million, compared to $0.7 million.
- Net income
attributable to ACM Research, Inc. was $30.9 million,
compared to $25.7 million. Non-GAAP net income attributable to ACM
Research, Inc., which excludes the effect of stock-based
compensation and unrealized gain (loss) on short-term investments,
was $42.4 million, compared to $37.6 million.
- Net income
per diluted share attributable to ACM Research, Inc. was
$0.45, compared to $0.39. Non-GAAP net income per diluted share,
which excludes the effect of stock-based compensation and
unrealized gain (loss) on short-term investments, was $0.63,
compared to $0.57.
- Cash and
cash equivalents, plus restricted cash and short-term and
long-term time deposits were $369.1 million at September 30, 2024,
compared to $366.8 million at June 30, 2024.
Conference Call Details
A conference call to discuss results will be
held on Thursday, November 7, 2024, at 8:00 a.m. Eastern Time (9:00
p.m. China Time). To join the conference call via telephone,
participants must use the following link to complete an online
registration process. Upon registering, each participant will
receive email instructions to access the conference call, including
dial-in information and a PIN number allowing access to the
conference call. This pre-registration process is designed by the
operator to reduce delays due to operator congestion when accessing
the live call.
Online Registration:
https://register.vevent.com/register/BIcf4dbc584cf54892966d5353590ab648
Participants who have not pre-registered may
join the webcast by accessing the link at
ir.acmrcsh.com/events.
A live and archived webcast will be available on
the Investors section of the ACM website at www.acmrcsh.com.
Use of Non-GAAP Financial
Measures
ACM presents non-GAAP gross margin, operating
expenses, operating income, net income attributable to ACM
Research, Inc. and basic and diluted earnings per share as
supplemental measures to GAAP financial measures regarding ACM’s
operational performance. These supplemental measures exclude the
impact of stock-based compensation, which ACM does not believe is
indicative of its core operating results. In addition, non-GAAP net
income attributable to ACM Research, Inc. and basic and diluted
earnings per share exclude the effect of stock-based compensation
and unrealized gain (loss) on short-term investments, which ACM
also believes are not indicative of its core operating results. A
reconciliation of each non-GAAP financial measure to the most
directly comparable GAAP financial measure is provided below under
“Reconciliation of GAAP to non-GAAP Financial Measures.”
ACM believes these non-GAAP financial measures
are useful to investors in assessing its operating performance. ACM
uses these financial measures internally to evaluate its operating
performance and for planning and forecasting of future periods.
Financial analysts may focus on and publish both historical results
and future projections based on the non-GAAP financial measures.
ACM also believes it is in the best interests of investors for ACM
to provide this non-GAAP information.
While ACM believes these non-GAAP financial
measures provide useful supplemental information to investors,
there are limitations associated with the use of these non-GAAP
financial measures. These non-GAAP financial measures may not be
reported by competitors, and they may not be directly comparable to
similarly titled measures of other companies due to differences in
calculation methodologies. The non-GAAP financial measures are not
an alternative to GAAP information and are not meant to be
considered in isolation or as a substitute for comparable GAAP
financial measures. They should be used only as a supplement to
GAAP information and should be considered only in conjunction with
ACM’s consolidated financial statements prepared in accordance with
GAAP.
Forward-Looking Statements
Certain statements contained in this press
release are not historical facts and may be forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Words such as “plans,” “expects,” “believes,”
“anticipates,” “designed,” and similar words are intended to
identify forward-looking statements. Forward-looking statements are
based on ACM management’s current expectations and beliefs, and
involve a number of risks and uncertainties that are difficult to
predict and that could cause actual results to differ materially
from those stated or implied by the forward-looking statements. A
description of certain of these risks, uncertainties and other
matters can be found in filings ACM makes with the U.S. Securities
and Exchange Commission, all of which are available at www.sec.gov.
Because forward-looking statements involve risks and uncertainties,
actual results and events may differ materially from results and
events currently expected by ACM. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. ACM undertakes no obligation to
publicly update these forward-looking statements to reflect events
or circumstances that occur after the date hereof or to reflect any
change in its expectations with regard to these forward-looking
statements or the occurrence of unanticipated events.
About ACM Research, Inc.ACM
develops, manufactures and sells semiconductor process equipment
for single-wafer or batch wet cleaning, electroplating, stress-free
polishing, vertical furnace processes, Track and PECVD, which are
critical to advanced semiconductor device manufacturing and
wafer-level packaging. ACM is committed to delivering customized,
high performance, cost-effective process solutions that
semiconductor manufacturers can use in numerous manufacturing steps
to improve productivity and product yield. For more information,
visit www.acmrcsh.com.
© ACM Research, Inc. ULTRA C and the ACM
Research logo are trademarks of ACM Research, Inc. For convenience,
these trademarks appear in this press release without ™ symbols,
but that practice does not mean that ACM will not assert, to the
fullest extent under applicable law, its rights to the
trademarks.
For investor and media inquiries, please
contact:
In the United States: |
The Blueshirt Group |
|
Steven C. Pelayo, CFA |
|
(360)808-5154 |
|
steven@blueshirtgroup.co |
|
|
In China: |
The Blueshirt Group Asia |
|
Gary Dvorchak, CFA |
|
+86 (138) 1079-1480 |
|
gary@blueshirtgroup.co |
ACM RESEARCH, INC.Condensed Consolidated
Balance Sheets |
|
|
September 30, 2024 |
|
December 31, 2023 |
|
(Unaudited) |
|
|
|
(In thousands) |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
333,472 |
|
|
$ |
182,090 |
|
Restricted cash |
|
1,782 |
|
|
|
1,083 |
|
Short-term time deposits |
|
20,304 |
|
|
|
80,524 |
|
Short-term investment |
|
20,351 |
|
|
|
21,312 |
|
Accounts receivable, net |
|
370,589 |
|
|
|
283,186 |
|
Other receivables |
|
57,849 |
|
|
|
40,065 |
|
Inventories, net |
|
628,720 |
|
|
|
545,395 |
|
Advances to related party |
|
1,453 |
|
|
|
2,432 |
|
Prepaid expenses |
|
10,794 |
|
|
|
20,023 |
|
Total current assets |
|
1,445,314 |
|
|
|
1,176,110 |
|
Property, plant and equipment,
net |
|
250,099 |
|
|
|
201,848 |
|
Land use right, net |
|
8,320 |
|
|
|
8,367 |
|
Operating lease right-of-use
assets, net |
|
5,680 |
|
|
|
7,026 |
|
Intangible assets, net |
|
2,838 |
|
|
|
2,538 |
|
Long-term time deposits |
|
13,517 |
|
|
|
40,818 |
|
Deferred tax assets |
|
13,400 |
|
|
|
20,271 |
|
Long-term investments |
|
33,655 |
|
|
|
27,880 |
|
Other long-term assets |
|
21,352 |
|
|
|
6,050 |
|
Total assets |
$ |
1,794,175 |
|
|
$ |
1,490,908 |
|
Liabilities and Equity |
|
|
|
Current liabilities: |
|
|
|
Short-term borrowings |
$ |
33,795 |
|
|
$ |
31,335 |
|
Current portion of long-term
borrowings |
|
30,670 |
|
|
|
6,783 |
|
Related party accounts
payable |
|
15,392 |
|
|
|
11,407 |
|
Accounts payable |
|
170,810 |
|
|
|
141,814 |
|
Advances from customers |
|
215,678 |
|
|
|
181,368 |
|
Deferred revenue |
|
10,138 |
|
|
|
3,687 |
|
Income taxes payable |
|
6,796 |
|
|
|
6,401 |
|
FIN-48 payable |
|
8,991 |
|
|
|
12,149 |
|
Other payables and accrued
expenses |
|
115,388 |
|
|
|
102,951 |
|
Current portion of operating
lease liability |
|
2,377 |
|
|
|
2,764 |
|
Total current liabilities |
|
610,035 |
|
|
|
500,659 |
|
Long-term borrowings |
|
106,069 |
|
|
|
53,952 |
|
Long-term operating lease
liability |
|
3,303 |
|
|
|
4,262 |
|
Other long-term liabilities |
|
5,685 |
|
|
|
5,873 |
|
Total liabilities |
|
725,092 |
|
|
|
564,746 |
|
Commitments and
contingencies |
|
|
|
Equity: |
|
|
|
Stockholders’ equity: |
|
|
|
Class A Common stock |
|
6 |
|
|
|
6 |
|
Class B Common stock |
|
1 |
|
|
|
1 |
|
Additional paid-in
capital |
|
669,540 |
|
|
|
629,845 |
|
Retained earnings |
|
229,374 |
|
|
|
156,827 |
|
Statutory surplus reserve |
|
30,060 |
|
|
|
30,060 |
|
Accumulated other
comprehensive loss |
|
(40,815 |
) |
|
|
(49,349 |
) |
Total ACM Research,
Inc. stockholders’ equity |
|
888,166 |
|
|
|
767,390 |
|
Non-controlling interests |
|
180,917 |
|
|
|
158,772 |
|
Total
equity |
|
1,069,083 |
|
|
|
926,162 |
|
Total liabilities and equity |
$ |
1,794,175 |
|
|
$ |
1,490,908 |
|
ACM RESEARCH, INC.Condensed Consolidated
Statements of Operations and Comprehensive
Income |
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(Unaudited) |
|
( In thousands, except share and per share data) |
Revenue |
$ |
203,976 |
|
|
$ |
168,569 |
|
|
$ |
558,647 |
|
|
$ |
387,402 |
|
Cost of revenue |
|
99,142 |
|
|
|
80,055 |
|
|
|
277,908 |
|
|
|
190,263 |
|
Gross profit |
|
104,834 |
|
|
|
88,514 |
|
|
|
280,739 |
|
|
|
197,139 |
|
Operating expenses: |
|
|
|
|
|
|
|
Sales and marketing |
|
15,759 |
|
|
|
16,803 |
|
|
|
47,067 |
|
|
|
37,579 |
|
Research and development |
|
27,837 |
|
|
|
26,151 |
|
|
|
77,723 |
|
|
|
60,244 |
|
General and administrative |
|
17,054 |
|
|
|
12,387 |
|
|
|
48,940 |
|
|
|
26,851 |
|
Total operating expenses |
|
60,650 |
|
|
|
55,341 |
|
|
|
173,730 |
|
|
|
124,674 |
|
Income from operations |
|
44,184 |
|
|
|
33,173 |
|
|
|
107,009 |
|
|
|
72,465 |
|
Interest income |
|
2,967 |
|
|
|
2,152 |
|
|
|
7,122 |
|
|
|
6,283 |
|
Interest expense |
|
(1,208 |
) |
|
|
(640 |
) |
|
|
(2,923 |
) |
|
|
(1,984 |
) |
Realized gain from sale of
short-term investments |
|
171 |
|
|
|
656 |
|
|
|
444 |
|
|
|
8,569 |
|
Unrealized gain (loss) on
short-term investments |
|
413 |
|
|
|
(1,319 |
) |
|
|
(1,151 |
) |
|
|
(4,428 |
) |
Other income (expense),
net |
|
(5,164 |
) |
|
|
(2,150 |
) |
|
|
(727 |
) |
|
|
156 |
|
Income (loss) from equity
method investments |
|
1,316 |
|
|
|
(160 |
) |
|
|
101 |
|
|
|
3,728 |
|
Income before income taxes |
|
42,679 |
|
|
|
31,712 |
|
|
|
109,875 |
|
|
|
84,789 |
|
Income tax expense |
|
(4,007 |
) |
|
|
(718 |
) |
|
|
(17,712 |
) |
|
|
(11,235 |
) |
Net income |
|
38,672 |
|
|
|
30,994 |
|
|
|
92,163 |
|
|
|
73,554 |
|
Less: Net income attributable
to non-controlling interests |
|
7,768 |
|
|
|
5,315 |
|
|
|
19,616 |
|
|
|
13,905 |
|
Net income attributable to ACM Research, Inc. |
$ |
30,904 |
|
|
$ |
25,679 |
|
|
$ |
72,547 |
|
|
$ |
59,649 |
|
Comprehensive income
(loss): |
|
|
|
|
|
|
|
Net income |
|
38,672 |
|
|
|
30,994 |
|
|
|
92,163 |
|
|
|
73,554 |
|
Foreign currency translation adjustment, net of
tax |
|
17,089 |
|
|
|
4,015 |
|
|
|
10,376 |
|
|
|
(21,831 |
) |
Comprehensive Income |
|
55,761 |
|
|
|
35,009 |
|
|
|
102,539 |
|
|
|
51,723 |
|
Less: Comprehensive income
attributable to non-controlling interests |
|
10,842 |
|
|
|
7,768 |
|
|
|
21,458 |
|
|
|
11,882 |
|
Comprehensive income (loss) attributable to ACM Research,
Inc. |
$ |
44,919 |
|
|
$ |
27,241 |
|
|
$ |
81,081 |
|
|
$ |
39,841 |
|
|
|
|
|
|
|
|
|
Net income attributable to ACM
Research, Inc. per common share: |
|
|
|
|
|
|
|
Basic |
$ |
0.49 |
|
|
$ |
0.43 |
|
|
$ |
1.17 |
|
|
$ |
0.99 |
|
Diluted |
$ |
0.45 |
|
|
$ |
0.39 |
|
|
$ |
1.07 |
|
|
$ |
0.90 |
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding used in computing per share amounts: |
|
|
|
|
|
|
|
Basic |
|
62,500,903 |
|
|
|
60,219,218 |
|
|
|
62,017,257 |
|
|
|
59,953,144 |
|
Diluted |
|
66,671,526 |
|
|
|
65,450,941 |
|
|
|
66,512,143 |
|
|
|
64,834,051 |
|
ACM RESEARCH, INC.Total Revenue by Product
Category and by Region |
|
|
Three Months EndedSeptember
30, |
|
Nine Months EndedSeptember
30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
(Unaudited) |
|
($ in thousand) |
Single wafer cleaning, Tahoe and semi-critical cleaning
equipment |
$ |
160,985 |
|
$ |
132,417 |
|
$ |
423,676 |
|
$ |
281,559 |
ECP (front-end and packaging),
furnace and other technologies |
|
34,600 |
|
|
25,508 |
|
|
99,362 |
|
|
71,223 |
Advanced packaging (excluding
ECP), services & spares |
|
8,391 |
|
|
10,644 |
|
|
35,609 |
|
|
34,620 |
Total Revenue By
Product Category |
$ |
203,976 |
|
$ |
168,569 |
|
$ |
558,647 |
|
$ |
387,402 |
|
Three Months EndedSeptember
30, |
|
Nine Months EndedSeptember
30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Mainland China |
$ |
203,672 |
|
$ |
168,302 |
|
$ |
552,642 |
|
$ |
375,528 |
Other Regions |
|
304 |
|
|
267 |
|
|
6,005 |
|
|
11,874 |
Total Revenue By
Region |
$ |
203,976 |
|
$ |
168,569 |
|
$ |
558,647 |
|
$ |
387,402 |
ACM RESEARCH, INC.Reconciliation of GAAP
to Non-GAAP Financial Measures |
As described under “Use of Non-GAAP Financial
Measures” above, ACM presents non-GAAP gross margin, operating
expenses, operating income, net income attributable to ACM
Research, Inc., and basic and diluted earnings per share as
supplemental measures to GAAP financial measures, each of which
excludes stock-based compensation (“SBC”) from the equivalent GAAP
financial line items. In addition, non-GAAP net income attributable
to ACM Research, Inc., and basic and diluted earnings per share
exclude unrealized gain (loss) on short-term investments. The
following tables reconcile gross margin, operating expenses,
operating income, net income attributable to ACM Research, Inc.,
and basic and diluted earnings per share to the related non-GAAP
financial measures:
|
Three Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
|
Actual(GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
Actual(GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
(In thousands) |
Revenue |
$ |
203,976 |
|
|
$ |
- |
|
|
$ |
- |
|
$ |
203,976 |
|
|
$ |
168,569 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
168,569 |
|
Cost of revenue |
|
(99,142 |
) |
|
|
(447 |
) |
|
|
- |
|
|
(98,695 |
) |
|
|
(80,055 |
) |
|
|
(588 |
) |
|
|
- |
|
|
|
(79,467 |
) |
Gross profit |
|
104,834 |
|
|
|
(447 |
) |
|
|
- |
|
|
105,281 |
|
|
|
88,514 |
|
|
|
(588 |
) |
|
|
- |
|
|
|
89,102 |
|
Gross margin |
|
51.4 |
% |
|
|
0.2 |
% |
|
|
- |
|
|
51.6 |
% |
|
|
52.5 |
% |
|
|
0.3 |
% |
|
|
- |
|
|
|
52.9 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
(15,759 |
) |
|
|
(2,594 |
) |
|
|
- |
|
|
(13,165 |
) |
|
|
(16,803 |
) |
|
|
(2,543 |
) |
|
|
- |
|
|
|
(14,260 |
) |
Research and development |
|
(27,837 |
) |
|
|
(3,373 |
) |
|
|
- |
|
|
(24,464 |
) |
|
|
(26,151 |
) |
|
|
(3,421 |
) |
|
|
- |
|
|
|
(22,730 |
) |
General and administrative |
|
(17,054 |
) |
|
|
(5,467 |
) |
|
|
- |
|
|
(11,587 |
) |
|
|
(12,387 |
) |
|
|
(4,029 |
) |
|
|
- |
|
|
|
(8,358 |
) |
Total operating expenses |
|
(60,650 |
) |
|
|
(11,434 |
) |
|
|
- |
|
|
(49,216 |
) |
|
|
(55,341 |
) |
|
|
(9,993 |
) |
|
|
- |
|
|
|
(45,348 |
) |
Income (loss) from
operations |
$ |
44,184 |
|
|
$ |
(11,881 |
) |
|
$ |
- |
|
$ |
56,065 |
|
|
$ |
33,173 |
|
|
$ |
(10,581 |
) |
|
$ |
- |
|
|
$ |
43,754 |
|
Unrealized gain (loss) on short-term investments |
|
413 |
|
|
|
- |
|
|
|
413 |
|
|
- |
|
|
|
(1,319 |
) |
|
|
- |
|
|
|
(1,319 |
) |
|
|
- |
|
Net income (loss)
attributable to ACM Research, Inc. |
$ |
30,904 |
|
|
$ |
(11,881 |
) |
|
$ |
413 |
|
$ |
42,372 |
|
|
$ |
25,679 |
|
|
$ |
(10,581 |
) |
|
$ |
(1,319 |
) |
|
$ |
37,579 |
|
Basic EPS |
$ |
0.49 |
|
|
|
|
|
|
$ |
0.68 |
|
|
$ |
0.43 |
|
|
|
|
|
|
$ |
0.62 |
|
Diluted EPS |
$ |
0.45 |
|
|
|
|
|
|
$ |
0.63 |
|
|
$ |
0.39 |
|
|
|
|
|
|
$ |
0.57 |
|
|
Nine Months Ended September 30, |
|
2024 |
|
2023 |
|
Actual(GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
Actual(GAAP) |
|
SBC |
|
Other non-operating
adjustments |
|
Adjusted(Non-GAAP) |
|
(In thousands) |
Revenue |
$ |
558,647 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
558,647 |
|
|
$ |
387,402 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
387,402 |
|
Cost of revenue |
|
(277,908 |
) |
|
|
(2,020 |
) |
|
|
- |
|
|
|
(275,888 |
) |
|
|
(190,263 |
) |
|
|
(838 |
) |
|
|
- |
|
|
|
(189,425 |
) |
Gross profit |
|
280,739 |
|
|
|
(2,020 |
) |
|
|
- |
|
|
|
282,759 |
|
|
|
197,139 |
|
|
|
(838 |
) |
|
|
- |
|
|
|
197,977 |
|
Gross margin |
|
50.3 |
% |
|
|
0.4 |
% |
|
|
- |
|
|
|
50.6 |
% |
|
|
50.9 |
% |
|
|
0.2 |
% |
|
|
- |
|
|
|
51.1 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
(47,067 |
) |
|
|
(8,645 |
) |
|
|
- |
|
|
|
(38,422 |
) |
|
|
(37,579 |
) |
|
|
(3,405 |
) |
|
|
- |
|
|
|
(34,174 |
) |
Research and development |
|
(77,723 |
) |
|
|
(12,082 |
) |
|
|
- |
|
|
|
(65,641 |
) |
|
|
(60,244 |
) |
|
|
(4,831 |
) |
|
|
- |
|
|
|
(55,413 |
) |
General and administrative |
|
(48,940 |
) |
|
|
(18,045 |
) |
|
|
- |
|
|
|
(30,895 |
) |
|
|
(26,851 |
) |
|
|
(5,592 |
) |
|
|
- |
|
|
|
(21,259 |
) |
Total operating expenses |
|
(173,730 |
) |
|
|
(38,772 |
) |
|
|
- |
|
|
|
(134,958 |
) |
|
|
(124,674 |
) |
|
|
(13,828 |
) |
|
|
- |
|
|
|
(110,846 |
) |
Income (loss) from
operations |
$ |
107,009 |
|
|
$ |
(40,792 |
) |
|
$ |
- |
|
|
$ |
147,801 |
|
|
$ |
72,465 |
|
|
$ |
(14,666 |
) |
|
$ |
- |
|
|
$ |
87,131 |
|
Unrealized gain (loss) on short-term investments |
|
(1,151 |
) |
|
|
- |
|
|
|
(1,151 |
) |
|
|
- |
|
|
|
(4,428 |
) |
|
|
- |
|
|
|
(4,428 |
) |
|
|
- |
|
Net income (loss)
attributable to ACM Research, Inc. |
$ |
72,547 |
|
|
$ |
(40,792 |
) |
|
$ |
(1,151 |
) |
|
$ |
114,490 |
|
|
$ |
59,649 |
|
|
$ |
(14,666 |
) |
|
$ |
(4,428 |
) |
|
$ |
78,743 |
|
Basic EPS |
$ |
1.17 |
|
|
|
|
|
|
$ |
1.85 |
|
|
$ |
0.99 |
|
|
|
|
|
|
$ |
1.31 |
|
Diluted EPS |
$ |
1.07 |
|
|
|
|
|
|
$ |
1.70 |
|
|
$ |
0.90 |
|
|
|
|
|
|
$ |
1.19 |
|
ACM Research (NASDAQ:ACMR)
Historical Stock Chart
From Oct 2024 to Nov 2024
ACM Research (NASDAQ:ACMR)
Historical Stock Chart
From Nov 2023 to Nov 2024